{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-003673","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.204822+00:00","generated_at":"2026-05-26T22:19:18.928964+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Autonomix Medical reports Q3 FY2025 net loss of $2.7M, cash $11.8M; PoC trial data on track for 1H2025","bullets":["Net loss of $2.7M for Q3 ended Dec 31, 2024 vs $3.1M a year ago; nine-month net loss $8.2M vs $10.0M.","Cash position $11.8M as of Dec 31, 2024; raised $10M in underwritten public offering during the quarter.","Topline proof-of-concept trial data for pancreatic cancer pain expected in 1H2025; US clinical trials targeted for 2H2025.","Achieved design lock for RF ablation catheter after successful animal testing; expanded IP with new U.S. patent grant.","Targeting De Novo submission in 2026 and potential FDA clearance for pancreatic cancer pain in 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-003673","json":"https://secwatch.observer/filing/0001437749-25-003673.json","markdown":"https://secwatch.observer/filing/0001437749-25-003673.md","text":"https://secwatch.observer/filing/0001437749-25-003673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000143774925003673/0001437749-25-003673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000143774925003673/amix20250210_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:19:18.928964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}